INTRODUCTION
In 1970, a multidisciplinary study was initiated
by the Peruvian government under my direction to
evaluate health conditions in a population group
which had lived in a relatively stable environment for
some 5,000 years. So far , American and Peruvian
archeologists , anthropologists , radiologists, anatomic, oral , neuro- and clinical pathologists, chemists,
immunologists , an otologist, and students from many
different disciplines have been involved in the study
which has been supported largely by the National
Geographic Society with many individual contributions .
We are often asked the va lue of such studies and
a simplistic answer would be, "what is the value of
any study of history?"
Many unanswered questions about the relationship of man and his diseases as well as some problems
on the origins of man and his migrations might be
partially solved through examination of anthropological material and studies of genetic markers . What are
the origins of man's diseases, many of which have
been described only within the last 200 years? Does
this mean they didn ' t exist before or have they appeared in a new form? What is the role of the environment in the appearance of a particular disease in a
population group? The Americas are unique in that
they are a vast land mass inhabited by a single racial
group, isolated for millennia , and with a well-documented history of discovery and colonization. This
area offers an opportunity for careful anthropological study of man before miscegenation and after;
nowhere in the world is such a wealth of anthropological data on a single racial group available in
conjunction with its food and artifacts . With colonization we can witness the exchange of disease from
one part of the world to another; for example, the
exchange of syphilis for tuberculosis was suggested or
the possible formation of a new disease, venereal
syphilis, from a nonvenereal relative . Such a study
might also serve as a baseline to measure the impact
of modern medicine in changing man's disease patterns.
Steps have been taken to answer some questions;
for example, we now know that tuberculosis was a
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disease present in native Americans as early as 700
A.O . and in the pre-Columbian Indian, it was probably much like the disease in the white American
prior to antibiotics. It was also a major cause of death
along with other respiratory diseases, and modern
medical practice has not changed this, since respiratory disease, including tuberculosis , is still the major cause of death in Latin America. Childhood illness 5,000 years ago was less than it is today and
mortality in infants and children was probably also
less. Problems of dental origin have become progressively worse since man first became a farmer and
although we have dentists today, it is questionable
whether they have improved the oral health of the
average man in rural Latin America.
Verification of the written word was made possible when we examined 22 miners from the 17th
century in this project. The extensive pneumoconiosis
due to silver ore and silica confirmed the statements
in the Spanish chronicles that the life expectancy of a
miner after he entered the pits was six months to a
year. In the same period, mistreatment of the Indians
under the colonial government was confirmed by a
nearly five hundred fold increase in fractures.
Serological study of ABO and HL-A antigens
have enabled us to trace the movements of prehistoric
peoples from one valley to another, and these, com bined with archeological and nonmetrical genetic markers, have enabled us to establish blood relationships
among individuals in the same cemetery . The absence
of a native written language has th us in part been
overcome. As yet, it has been impossible for us to
establish the presence or absence of soft tissue syphilis nor have we been able to discover any new diseases. We do feel there were fewer virulent agents of
wound infection in prehistoric Peru, but documentation as to why this is so is poor, although theories are
not lacking. We hope in time to establish good, epidemiological data to answer some of these questions as
well as many more that will surely arise as our investigations proceed.
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